BeStock  
Stocks › Biotechnology › IMVT

Immunovant IMVT

US equityMarket cap rank #1778Biotechnology
$31.77 −$0.75 (-2.31%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $31.51 -0.82%
Open$32.26
Prev close$32.52
Day range$31.61 – $32.77
Volume704.9K
Market cap$6.57B
P/E (TTM)–
Dividend yield–

IMVT Stock News

Headlines matching Immunovant or the IMVT ticker, most recent first.

  • LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $53Market news · 26 Sep 2026 · Direct mention
  • Bernstein Initiates Immunovant(IMVT.US) With Hold Rating, Announces Target Price $37Market news · 26 Sep 2026 · Direct mention
  • Truist Financial Maintains Immunovant(IMVT.US) With Hold RatingMarket news · 24 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $41Market news · 24 Sep 2026 · Direct mention
  • Piper Sandler Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $66Market news · 21 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $41 to $66Market news · 8 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $41 PositiveMarket news · 7 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $50 PositiveMarket news · 4 Aug 2026 · Direct mention
  • Stifel Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $57 PositiveMarket news · 13 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $50Market news · 10 Aug 2026 · Direct mention
  • J.P. Morgan Sticks to Their Buy Rating for Immunovant (IMVT)TipRanks · 10 Aug 2026 · Direct mention
  • LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $53 PositiveMarket news · 9 Jul 2026 · Direct mention
  • Citi Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $61 PositiveMarket news · 30 Jun 2026 · Direct mention
  • J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $47 PositiveMarket news · 27 May 2026 · Direct mention
  • H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $40Market news · 26 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on IMVT.

Sign in to join the discussion.

Scroll to Top